Coty
Track in portfolio
Price chart
Description
Company and Business Model
Coty Inc. is a global beauty company specializing in cosmetics, skincare, fragrances, and hair color. Its core products include makeup brands such as CoverGirl and Rimmel, as well as fragrances under licenses for brands like Calvin Klein and Gucci. Major business segments consist of Consumer Beauty, Luxury, and Professional Beauty, with revenue primarily generated from retail sales and e-commerce channels. The company focuses on innovation and brand development to enhance its market position.
Investment Profile
The investment profile of Coty suggests it may be more suitable for value investors seeking potential recovery in a challenging market environment. The company's recent performance indicates significant volatility and risk, which may deter growth-focused investors. Given the lack of dividends and the current financial challenges, a balanced approach may be prudent for those considering exposure to the consumer staples sector.
Fundamental metrics (experimental) Updated: 2026-07-26
- EPS (TTM) — earnings per share for the last 12 months, $
- -0.62
- Revenue QoQ — quarter-over-quarter revenue growth
- -23.7%
- EPS surprise
- -3070.3%
- 20d volatility
- 2.8%
- last ex-date
- 2020-02-14
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-05-08 | — | Sell | scenario_deterioration |
| 2026-05-08 | Sell | Sell | Компания Coty демонстрирует нестабильные результаты, с отрицательным EPS и значительным падением за последние 120 дней. Однако недавний рост выручки и положительная динамика за последние 20 дней могут свидетельствовать о |
| 2026-03-19 | Hold | Sell | scenario_deterioration |
| 2026-03-11 | Sell | Hold | Компания Coty демонстрирует значительное снижение цены акций за последние месяцы, а отрицательный EPS указывает на финансовые трудности. Учитывая высокие риски и негативные тренды, рекомендуется продавать. |
| 2026-02-08 | — | Sell | Компания Coty демонстрирует значительное падение котировок за последние месяцы, что указывает на высокие риски. Отсутствие данных о прибыли и выручке также вызывает сомнения в стабильности бизнеса. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-05-07 | Morgan Stanley | Target Raised | 2.25 → 2.5 | 2.485 |
| 2026-04-14 | Barclays | Target Lowered | 2.5 → 2 | 2.314 |
| 2026-02-09 | RBC Capital | Target Lowered | 10 → 8 | 2.495 |
| 2026-02-09 | Morgan Stanley | Target Lowered | 4.25 → 3.5 | 2.66 |
| 2026-02-09 | Canaccord Genuity | Target Lowered | 3.5 → 2.5 | 2.64 |
| 2026-02-09 | Goldman Sachs | Target Lowered | 3.8 → 2.5 | 2.66 |
| 2026-02-09 | Barclays | Target Lowered | 3 → 2.5 | 2.66 |
| 2026-02-02 | Canaccord Genuity | Target Lowered | 4 → 3.5 | 3.17 |
| 2026-01-16 | Barclays | Target Lowered | 3.5 → 3 | 3.095 |
| 2026-01-14 | Jefferies | Update | — → 3.5 | 3.19 |
News Page 1 of 1
Nothing yet